Study CB-839 in Combination With Nivolumab in Patients With Melanoma, Clear Cell Renal Cell Carcinoma (ccRCC) and Non-Small Cell Lung Cancer (NSCLC)

New York University, New York

Columbia University Medical Center, New York

Memorial Sloan Kettering Cancer Center, New York

University of Pennsylvania, Philadelphia

University Cancer Blood Center, Athens

Vanderbilt University, Nashville

University Hospitals Cleveland, Cleveland

Karmanos Caner Center, Detroit

University of Texas MD Anderson Cancer Center, Houston

University of Colorado, Aurora

Honor Health, Scottsdale

Stanford University, Palo Alto

Seattle Cancer Care Alliance/University of Washington, Seattle

Northwest Medical Specialties, Tacoma

Beth Israel Deaconess Medical Center, Boston

Massachusetts General Hospital, Boston

Dana-Farber Cancer Institute, Boston